954 — Changmao Biochemical Engineering Co Income Statement
0.000.00%
Last trade - 00:00- HK$166.86m
- HK$706.72m
- CNY556.93m
Annual income statement for Changmao Biochemical Engineering Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 548 | 730 | 637 | 585 | 557 |
| Cost of Revenue | |||||
| Gross Profit | 38.7 | 181 | 25.8 | 16.8 | 17.8 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 462 | 641 | 689 | 642 | 605 |
| Operating Profit | 85.8 | 89.4 | -52 | -57.1 | -48.4 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | 84.4 | 87.6 | -58.6 | -67.6 | -65 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 58.2 | 81.4 | -86.5 | -68.3 | -67.2 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 58.3 | 81.4 | -86.1 | -68.2 | -66.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 58.3 | 81.4 | -86.1 | -68.2 | -66.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.007 | 0.177 | -0.114 | -0.081 | -0.115 |
| Dividends per Share |